Margareth Jorvid | Board Member
Elicera Therapeutics

Margareth Jorvid, Board Member, Elicera Therapeutics

Margareth Jorvid – MSc Pharm, MSc MTRA, MBA, FTOPRA Methra Uppsala AB CEO, Regulatory Affairs & Quality Assurance Margareth Jorvid has over 30 years of experience in Regulatory Affairs and has worked at the Swedish Medical Products Agency (MPA) as well as large and small pharmaceutical and biotech companies, such as Roussel Nordiska, Hoechst Marion Roussel (in Stockholm and Paris, France) and Neopharma. Since 2006, consultant in regulatory affairs and QA for pharmaceuticals, ATMP (cell- and gene therapies), medical devices and combination products through her company Methra Uppsala AB, LSM group. She holds a MSc Pharm from Uppsala University, a MBA from Stockholm School of Economics, Sweden and a MSc MTRA from Cranfield University, UK.

Appearances:



Advanced Therapies USA 2026 - Day 2 @ 13:05

Effectively interacting with regulatory authorities

Advanced Therapies USA 2026 - Day 2 @ 14:05

Panel Discussion: Navigating the Global Regulatory Landscape for Commercial Approval

last published: 24/Jun/26 18:25 GMT

back to speakers

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit

Matthew Belmoh
Matthew.Belmoh@terrapinn.com
+44 7301058795

 

To speak

Chris Shanks
chris.shanks@terrapinn.com
+02034332221